{"id":5319,"date":"2020-06-01T11:54:43","date_gmt":"2020-06-01T10:54:43","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=5319"},"modified":"2020-06-01T11:54:43","modified_gmt":"2020-06-01T10:54:43","slug":"developing-passive-immunotherapy-methods-for-covid-19","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/","title":{"rendered":"Developing passive immunotherapy methods for COVID-19"},"content":{"rendered":"

New Horizon 2020 project aims to develop passive immunotherapy methods against COVID-19 using antibodies from recovered patients.<\/h2>\n

The new Horizon 2020 project, Antibody Therapy Against Coronavirus<\/a> (ATAC), aims to develop passive immunotherapy methods against COVID-19<\/a>. The research team are currently using human antibodies from recovered COVID-19 patients to test different passive immunotherapy methods.<\/p>\n

According to a recently published ATAC fact sheet: \u2018Antibodies will be characterised by rapid experimental and computational work, optimised, produced and tested in consultation with EMA to ensure prompt embedding of regulatory aspects.\u2019<\/p>\n

Successful methods using blood plasma<\/h3>\n

The team from the ATAC project consortium have tested blood plasma transfusions<\/a> in patients and discovered that this method can provide promising results. Unfortunately, a single plasma donation can only treat one person.<\/p>\n

\u201cThere is quite a difference between patients in terms of how many antibodies they have. You can go from almost nothing to quite impressive immune responses,\u201d said Dr Rino Rappuoli, an internationally recognised vaccinologist working on the ATAC project.<\/p>\n

\u201cIt seems great: it\u2019s quick, it’s easy, it’s simple, but it’s not the most convenient treatment long term,\u201d said Dr Luca Varani from the Institute for Research in Biomedicine, Universit\u00e0 della Svizzera italiana<\/a> in Switzerland.<\/p>\n

A monoclonal approach to passive immunotherapy<\/h3>\n

The ATAC team aim to develop alternative, large-scale, passive immunotherapy methods using monoclonal antibodies. Scientists are currently searching for a single antibody that can fight COVID-19 in order to replicate and mass produce it. The use of lab-produced or monoclonal antibodies has previously been successful in the fight against diseases like cancer and arthritis.<\/p>\n

\u201cI believe human monoclonal antibodies are the best way to develop quickly a drug that is going to cure the infection. We don’t know yet the quality of the antibodies that come from the patients.<\/p>\n

\u201cWe are at the stage where we have several hundreds of positives, and we are starting the screening. So we may already have the antibody, but we don’t know yet,\u201d said Rappuoli.<\/p>\n","protected":false},"excerpt":{"rendered":"

New Horizon 2020 project aims to develop passive immunotherapy methods against COVID-19 using antibodies from recovered patients. The new Horizon 2020 project, Antibody Therapy Against Coronavirus (ATAC), aims to develop passive immunotherapy methods against COVID-19. The research team are currently using human antibodies from recovered COVID-19 patients to test different passive immunotherapy methods. According to […]<\/p>\n","protected":false},"author":4,"featured_media":5320,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[10551],"tags":[16871],"acf":[],"yoast_head":"\nDeveloping passive immunotherapy methods for COVID-19<\/title>\n<meta name=\"description\" content=\"New Horizon 2020 project aims to develop passive immunotherapy methods against COVID-19 using antibodies from recovered patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Developing passive immunotherapy methods for COVID-19\" \/>\n<meta property=\"og:description\" content=\"New Horizon 2020 project aims to develop passive immunotherapy methods against COVID-19 using antibodies from recovered patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovation News Network\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/InnoNewsNetwork\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-01T10:54:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy-1024x576.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Caitlin Magee\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@InnoNewsNetwork\" \/>\n<meta name=\"twitter:site\" content=\"@InnoNewsNetwork\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caitlin Magee\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/\"},\"author\":{\"name\":\"Caitlin Magee\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/person\/5186ad57c79ad5162638977775a065d2\"},\"headline\":\"Developing passive immunotherapy methods for COVID-19\",\"datePublished\":\"2020-06-01T10:54:43+00:00\",\"dateModified\":\"2020-06-01T10:54:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/\"},\"wordCount\":330,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy.jpg\",\"keywords\":[\"COVID-19\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#respond\"]}],\"copyrightYear\":\"2020\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/\",\"url\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/\",\"name\":\"Developing passive immunotherapy methods for COVID-19\",\"isPartOf\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy.jpg\",\"datePublished\":\"2020-06-01T10:54:43+00:00\",\"dateModified\":\"2020-06-01T10:54:43+00:00\",\"description\":\"New Horizon 2020 project aims to develop passive immunotherapy methods against COVID-19 using antibodies from recovered patients.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#primaryimage\",\"url\":\"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy.jpg\",\"contentUrl\":\"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"\u00a9 iStock\/wildpixel\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.innovationnewsnetwork.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Developing passive immunotherapy methods for COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#website\",\"url\":\"https:\/\/www.innovationnewsnetwork.com\/\",\"name\":\"Innovation News Network\",\"description\":\"Science, Research & Innovation News\",\"publisher\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.innovationnewsnetwork.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#organization\",\"name\":\"Innovation News Network\",\"url\":\"https:\/\/www.innovationnewsnetwork.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2022\/01\/inn-logo-yoast-seo-organisation-1920-1080-001.jpg\",\"contentUrl\":\"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2022\/01\/inn-logo-yoast-seo-organisation-1920-1080-001.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"Innovation News Network\"},\"image\":{\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/InnoNewsNetwork\",\"https:\/\/x.com\/InnoNewsNetwork\",\"https:\/\/www.linkedin.com\/company\/innovation-news-network\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/person\/5186ad57c79ad5162638977775a065d2\",\"name\":\"Caitlin Magee\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9317ff5b599c1691af439d8adbf8433d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9317ff5b599c1691af439d8adbf8433d?s=96&d=mm&r=g\",\"caption\":\"Caitlin Magee\"},\"sameAs\":[\"https:\/\/www.innovationnewsnetwork.com\"],\"url\":\"https:\/\/www.innovationnewsnetwork.com\/author\/caitlinmagee\/\"}]}<\/script>\n","yoast_head_json":{"title":"Developing passive immunotherapy methods for COVID-19","description":"New Horizon 2020 project aims to develop passive immunotherapy methods against COVID-19 using antibodies from recovered patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/","og_locale":"en_GB","og_type":"article","og_title":"Developing passive immunotherapy methods for COVID-19","og_description":"New Horizon 2020 project aims to develop passive immunotherapy methods against COVID-19 using antibodies from recovered patients.","og_url":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/","og_site_name":"Innovation News Network","article_publisher":"https:\/\/www.facebook.com\/InnoNewsNetwork","article_published_time":"2020-06-01T10:54:43+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy-1024x576.jpg","type":"image\/jpeg"}],"author":"Caitlin Magee","twitter_card":"summary_large_image","twitter_creator":"@InnoNewsNetwork","twitter_site":"@InnoNewsNetwork","twitter_misc":{"Written by":"Caitlin Magee","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#article","isPartOf":{"@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/"},"author":{"name":"Caitlin Magee","@id":"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/person\/5186ad57c79ad5162638977775a065d2"},"headline":"Developing passive immunotherapy methods for COVID-19","datePublished":"2020-06-01T10:54:43+00:00","dateModified":"2020-06-01T10:54:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/"},"wordCount":330,"commentCount":0,"publisher":{"@id":"https:\/\/www.innovationnewsnetwork.com\/#organization"},"image":{"@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#primaryimage"},"thumbnailUrl":"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy.jpg","keywords":["COVID-19"],"articleSection":["Health"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#respond"]}],"copyrightYear":"2020","copyrightHolder":{"@id":"https:\/\/www.innovationnewsnetwork.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/","url":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/","name":"Developing passive immunotherapy methods for COVID-19","isPartOf":{"@id":"https:\/\/www.innovationnewsnetwork.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#primaryimage"},"image":{"@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#primaryimage"},"thumbnailUrl":"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy.jpg","datePublished":"2020-06-01T10:54:43+00:00","dateModified":"2020-06-01T10:54:43+00:00","description":"New Horizon 2020 project aims to develop passive immunotherapy methods against COVID-19 using antibodies from recovered patients.","breadcrumb":{"@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#primaryimage","url":"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy.jpg","contentUrl":"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2020\/06\/passive-immunotherapy.jpg","width":1920,"height":1080,"caption":"\u00a9 iStock\/wildpixel"},{"@type":"BreadcrumbList","@id":"https:\/\/www.innovationnewsnetwork.com\/developing-passive-immunotherapy-methods-for-covid-19\/5319\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.innovationnewsnetwork.com\/"},{"@type":"ListItem","position":2,"name":"Developing passive immunotherapy methods for COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.innovationnewsnetwork.com\/#website","url":"https:\/\/www.innovationnewsnetwork.com\/","name":"Innovation News Network","description":"Science, Research & Innovation News","publisher":{"@id":"https:\/\/www.innovationnewsnetwork.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.innovationnewsnetwork.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.innovationnewsnetwork.com\/#organization","name":"Innovation News Network","url":"https:\/\/www.innovationnewsnetwork.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2022\/01\/inn-logo-yoast-seo-organisation-1920-1080-001.jpg","contentUrl":"https:\/\/www.innovationnewsnetwork.com\/wp-content\/uploads\/2022\/01\/inn-logo-yoast-seo-organisation-1920-1080-001.jpg","width":1920,"height":1080,"caption":"Innovation News Network"},"image":{"@id":"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/InnoNewsNetwork","https:\/\/x.com\/InnoNewsNetwork","https:\/\/www.linkedin.com\/company\/innovation-news-network\/"]},{"@type":"Person","@id":"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/person\/5186ad57c79ad5162638977775a065d2","name":"Caitlin Magee","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.innovationnewsnetwork.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9317ff5b599c1691af439d8adbf8433d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9317ff5b599c1691af439d8adbf8433d?s=96&d=mm&r=g","caption":"Caitlin Magee"},"sameAs":["https:\/\/www.innovationnewsnetwork.com"],"url":"https:\/\/www.innovationnewsnetwork.com\/author\/caitlinmagee\/"}]}},"publishpress_future_action":{"enabled":false,"date":"2025-02-07 10:52:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/posts\/5319"}],"collection":[{"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/comments?post=5319"}],"version-history":[{"count":1,"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/posts\/5319\/revisions"}],"predecessor-version":[{"id":5321,"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/posts\/5319\/revisions\/5321"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/media\/5320"}],"wp:attachment":[{"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/media?parent=5319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/categories?post=5319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.innovationnewsnetwork.com\/wp-json\/wp\/v2\/tags?post=5319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}